IQVIA Holdings | IQV - Operating Expenses


IQVIA Holdings reported $3.82B in Operating Expenses for its fiscal quarter ending in September of 2026.





Operating Expenses Change Date
Accenture USD 15.82B 272.85M Jun/2026
Agilent USD 1.43B 2M Jun/2026
Bruker USD 790.5M 21.6M Sep/2026
Cardinal Health USD -3.03B 65.88B Sep/2026
Celltrion KRW 133.99B 14.77B Jun/2026
Charles River Laboratories USD 3.23B 387.38M Sep/2026
Cigna USD 43.38B 763M Sep/2026
Cognizant Technology Solutions USD 14.73B 10.12B Sep/2026
Cspc Pharmaceutical CNY 5.91B 512.77M Dec/2025
CVS Health USD 104.83B 5.47B Sep/2026
Danaher USD 53.62B 1.04B Sep/2026
Dentsply International USD 1.36B 4M Sep/2026
Deva Holding AS TRY 1.35B 178.26M Sep/2023
Dianthus Therapeutics USD 62.24M 15.25M Jun/2026
Divis Laboratories Ltd INR 22.52B 3.01B Sep/2026
Elevance Health USD 49.28B 4.39B Sep/2026
Humana USD 18.83B 20.68B Sep/2026
IBM USD 14.63B 87M Sep/2026
Illumina USD 525M 374M Sep/2026
Infosys INR 388.5B 388.32B Sep/2026
Kangmei Pharma CNY 1.22B 130.32M Jun/2026
Knight Therapeutics CAD 126.9M 8.29M Dec/2025
Laboratorios Farma EUR 313.62M 17.98M Dec/2023
Laboratory Of America USD 3.39B 117.6M Sep/2026
Malin Corporation EUR 1.1M 400K Dec/2024
McKesson USD 109.27B 5.31B Sep/2026
Mettler Toledo International USD 77.66M 662.11M Sep/2026
Organigram Holdings CAD 100.45M 30.86M Jun/2026
Ovoca Bio EUR 173K 990K Dec/2025
Pharma Mar EUR 46.77M 4.24M Sep/2026
Publicis EUR 7.58B 51M Jun/2026
Qiagen NV USD 393.64M 17.95M Jun/2026
Quest Diagnostics USD 2.62B 34M Sep/2026
Revvity USD 604.27M 719K Sep/2026
Sartorius EUR 746.5M 1.3M Sep/2026
Sino Biopharmaceutical CNY 12.39B 1.26B Jun/2025
Thermo Fisher Scientific USD 9.68B 134M Sep/2026
Tilray USD 237.52M 17.34M Sep/2025
UnitedHealth USD 106.35B 2.31B Sep/2026
Veeva Systems USD 652.94M 43.11M Jun/2026
Veradigm USD 188M 61.08M Dec/2022
Waters USD 527M 592M Jun/2026
Zealand Pharma A/S 573M 202.97M Mar/2026
Zz Pientze Pharmaceu CNY 1.54B 90.74M Sep/2026